Hikma Pharmaceuticals eyes $1 billion purchase of CorePharma

Wednesday, 24 September 2014, 2:05 am

I realise most of the dealmaking community is currently focused on the risk that some large pharmaceutical deals may collapse. But I have stumbled across a potential pharmaceutical deal that is unlikely to be affected by the US government's attempt to clamp down on corporate "tax inversions"...

Register

Register for free to see rest of this article and all public articles from Betaville

Login / Register


[Disclaimer - the information on Betaville does not consitute any form of investment recommendation and is not intended to be relied upon by readers in making, or refraining from, any investment decisions].

Post Comment